Isosorbide-hydralazine combination clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2001
How each study uses isosorbide-hydralazine combination is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- BiDil
- 2
Studies by the year they started
3 studies that test it; most in 2001 (1)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2015 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Henrik Wiggers (1) · Arbor Pharmaceuticals, Inc. (1) · Nitromed (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses isosorbide-hydralazine combination is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- DANHEART (H-HeFT and Met-HeFT)CompletedPhase 4Henrik WiggersNCT03514108Written as Hydralazine Isosorbide DinitrateHow we know
- Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil TabletsCompletedPhase 1Arbor Pharmaceuticals, Inc.NCT02522208Written as BiDil XRHow we know
- African-American Heart Failure TrialCompletedPhase 4NitromedNCT00047775Written as BiDilHow we know